Naoki Tojo1, Atsushi Hayashi2, Tomoko Consolvo-Ueda2, Shuichiro Yanagisawa2. 1. Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. tojo-naoki@umin.ac.jp. 2. Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Abstract
PURPOSE: We compared the outcomes of Baerveldt glaucoma implant (BGI) surgery between vitreous cavity and anterior chamber insertion. METHODS: We retrospectively analyzed a total of 105 consecutive eyes that underwent BGI surgery and were followed up for ≥ 12 months. BGI surgery was performed via the anterior chamber (AC group 48 eyes) or the pars plana into the vitreous cavity (VC group 57 eyes). Patients' data were examined at 3, 6, and 12 months, and then every 6 months after surgery. We compared the groups' intraocular pressure (IOP), success ratio, visual acuity, number of glaucoma medications, central corneal endothelial cell density (CCECD), reduction ratio of CCECD, and postoperative complications. RESULTS: The mean preoperative and postoperative IOP values were not significantly different between the two groups. In the Kaplan-Meier survival plots, there was no significant between-group difference in the success rate (p = 0.333). The postoperative mean CCECD decreased significantly faster in the AC group than the VC group at all time points. The cases of postoperative corneal edema were 12.5% in AC group and 1.8% in VC group. The risk of postoperative corneal edema was significantly higher in the AC group (p = 0.0136). Risk factors for the rapid reduction of CCECD were "history of trabeculectomy" (p = 0.00283), "insertion into the anterior chamber" (p = 0.001), and "shorter distance between the tube and corneal endothelium" (p = 0.0137). CONCLUSION: There was no significant between-group difference in postoperative IOP, medications, or success rate. Considering the reduction of corneal endothelial cells, insertion into the vitreous cavity seems safer than insertion into the anterior chamber.
PURPOSE: We compared the outcomes of Baerveldt glaucoma implant (BGI) surgery between vitreous cavity and anterior chamber insertion. METHODS: We retrospectively analyzed a total of 105 consecutive eyes that underwent BGI surgery and were followed up for ≥ 12 months. BGI surgery was performed via the anterior chamber (AC group 48 eyes) or the pars plana into the vitreous cavity (VC group 57 eyes). Patients' data were examined at 3, 6, and 12 months, and then every 6 months after surgery. We compared the groups' intraocular pressure (IOP), success ratio, visual acuity, number of glaucoma medications, central corneal endothelial cell density (CCECD), reduction ratio of CCECD, and postoperative complications. RESULTS: The mean preoperative and postoperative IOP values were not significantly different between the two groups. In the Kaplan-Meier survival plots, there was no significant between-group difference in the success rate (p = 0.333). The postoperative mean CCECD decreased significantly faster in the AC group than the VC group at all time points. The cases of postoperative corneal edema were 12.5% in AC group and 1.8% in VC group. The risk of postoperative corneal edema was significantly higher in the AC group (p = 0.0136). Risk factors for the rapid reduction of CCECD were "history of trabeculectomy" (p = 0.00283), "insertion into the anterior chamber" (p = 0.001), and "shorter distance between the tube and corneal endothelium" (p = 0.0137). CONCLUSION: There was no significant between-group difference in postoperative IOP, medications, or success rate. Considering the reduction of corneal endothelial cells, insertion into the vitreous cavity seems safer than insertion into the anterior chamber.
Authors: M J Suárez-Fernández; E Gutiérrez-Díaz; A Julve San Martín; M F Fernández-Reyes; E Mencía-Gutiérrez Journal: Arch Soc Esp Oftalmol Date: 2010-03
Authors: Giamberto Casini; Pasquale Loiudice; Marco Pellegrini; Angela Tindara Sframeli; Paolo Martinelli; Andrea Passani; Marco Nardi Journal: Am J Ophthalmol Date: 2015-08-22 Impact factor: 5.258
Authors: Thalmon R Campagnoli; Sung Soo Kim; William E Smiddy; Steve J Gedde; Donald L Budenz; Richard K Parrish; Paul F Palmberg; William Feuer; Wei Shi Journal: Int J Ophthalmol Date: 2015-10-18 Impact factor: 1.779
Authors: Joseph F Panarelli; Michael R Banitt; Steven J Gedde; Wei Shi; Joyce C Schiffman; William J Feuer Journal: Ophthalmology Date: 2015-12-30 Impact factor: 12.079
Authors: S W Siegner; P A Netland; R C Urban; A S Williams; D W Richards; M A Latina; J D Brandt Journal: Ophthalmology Date: 1995-09 Impact factor: 12.079
Authors: Sandy Samuel; Enchi K Chang; Sanchay Gupta; Marika Chachanidze; Cameron E Neeson; John B Miller; Ta Chen Chang; David A Solá-Del Valle Journal: J Ophthalmol Date: 2022-07-20 Impact factor: 1.974
Authors: Sean Yonamine; Lauren Ton; Jennifer Rose-Nussbaumer; Gui-Shuang Ying; Iqbal Ike K Ahmed; Teresa C Chen; Asher Weiner; Steven J Gedde; Ying Han Journal: Clin Ophthalmol Date: 2022-07-21